Sabitlenmiş Tweet
We're honored that @Newsweek has recognized Siteman as the No. 1 cancer center in Missouri and Illinois — and among the best of the best nationally.
siteman.wustl.edu/newsweek-names…
English
Siteman Cancer Center
7.1K posts
Siteman Cancer Center
@SitemanCenter
Leading cancer care from prevention to survivorship with advanced research, individualized treatment, and dedicated care coordination support.
St. Louis, MO Katılım Kasım 2009
2.4K Takip Edilen33.3K Takipçiler
Congratulations to @washumedicine's Cynthia X. Ma, MD, PhD, on receiving a Susan G. Komen Leadership Grant. Ma, a medical oncologist at Siteman, aims to guide more personalized treatment for breast cancer by studying why certain cancers become resistant to hormone therapy.
English
Congratulations to @washumedicine's Graham A. Colditz, MD, DrPH, and Shu (Joy) Jiang, PhD, on receiving the 2026 Chancellor's Award for Innovation and Entrepreneurship for their AI mammography technology that predicts personalized breast cancer risk. siteman.wustl.edu/colditz-jiang-…
English
Happy New Academic Year!
We are excited to welcome four residents who begin their #radonc training with us today!
Julia Balmaceda, MD, Keegan Christensen, MD, Christopher Cronkite, MD, PhD & Nisitha Sengottuvel, MD, PhD - welcome to the team!
English
Congratulations to @washumedicine's Gregory J. Zipfel, MD, on being elected president of the Society of Neurological Surgeons. He is the fifth chair of the Taylor Family Department of Neurosurgery to lead the society, a legacy dating back to 1920. siteman.wustl.edu/zipfel-install…
English
Optical Biopsy. Less than three minutes. @washumedicine researchers at Siteman developed a new 3D optical imaging method combined with machine learning to detect early endometrial cancer with 94% sensitivity. siteman.wustl.edu/quick-optical-…
English
New from @washumedicine and Siteman: Younger generations are aging faster biologically, and that accelerated aging is linked to rising early-onset cancer rates. Led by Yin Cao, ScD, MPH. Learn more: siteman.wustl.edu/faster-aging-i…
GIF
English
What if what you eat feeds a tumor? @washu’s Gary Patti, PhD, of Siteman Cancer Center, is tracking how cancer cells feed themselves — and one finding is already turning heads: fructose fuels tumor growth. siteman.wustl.edu/targeting-tumo…
English
Congratulations to @washumedicine's Ravi Vij, MD, of Siteman on this well-deserved honor. He has written 300+ papers and led multiple innovative clinical trials in blood cancer. siteman.wustl.edu/vij-named-inau…
English
Smoking duration v. pack-years: After analyzing data from nearly 1M vets, @washumedicine's Brendan Heiden, MD, suggests duration metrics may better identify individuals at higher risk for lung cancer: ascopost.com/videos/asco-20… #ASCO26
English
As #ASCO26 wraps up, take a look at the @washumedicine research presented by Siteman members, including breakthroughs in head and neck, endometrial cancers and more: siteman.wustl.edu/siteman-cancer…
English
New from #ASCO26: @washumedicine’s Brendan Heiden, MD, suggests a paradigm shift in lung cancer screening: changing the metric from tobacco-pack years to tobacco smoking duration. Learn more: dailynews.ascopubs.org/do/new-lung-ca…
English
Food insecurity and financial stress can negatively impact the biology of breast cancer and the outcomes of patients, @washumedicine medical oncologist Emily Podany, MD, of Siteman Cancer Center, tells us.
Watch her discuss these findings, which she presented at #ASCO26.
English
Siteman Cancer Center retweetledi
From Bench-to-Beside! WashU Hematology is excited to bring this research from the Oh Lab (@mpndoc) all the way to a clinical trial offered at @SitemanCenter. #TranslationalResearch
WashU Medicine Department of Medicine@WashUDeptMed
Congrats Amy Zhou, MD @WashUHematology on launching a new clinical trial of PMD-026 for chronic myelofibrosis patients who failed or are intolerant to JAK inhibitors—built on discoveries from Dr. Stephen Oh’s lab in collab with Phoenix Molecular Designs. bit.ly/4ebpOW5
English
The KEYNOTE-689 trial of pembro in locally advanced H&N cancer has yielded practice-changing results. Looking ahead, data from the study could help trial leaders, including Douglas Adkins, MD, develop more strategies to enhance survivability. #ASCO26
English
With ongoing support, the best minds in cancer research can meet the challenge for the greater good of patients, said @washumedicine surgeon Sidharth Puram, MD, PhD, FACS, co-director of the Head & Neck Tumor Center at Siteman Cancer Center. #ASCO26.
English
Siteman Cancer Center retweetledi
There’s new hope for patients diagnosed with neuroendocrine tumors. @washumedicine medical oncologist Nikolaos A. Trikalinos, MD, MS, of Siteman Cancer Center, discusses the advances, which he presented at #ASCO26.
English
Great article, @TargetedOnc!
Kudos to Dr. McCourt, RUBY co-author, on her interview below and lead author and @asco presenter Dr. Powell on this incredible clinical trial striving towards extending the lives of those with advanced or recurrent endometrial cancer.
Targeted Oncology@TargetedOnc
🎥 WATCH: At #SGOAM26, Matthew Powell, MD (@washumedicine) discussed long-term overall survival results with dostarlimab plus chemo in dMMR #EndometrialCancer patients from the RUBY trial. #GynOnc targetedonc.com/view/dostarlim…
English
#ASCO26: Time is running out! Meet Chair and Moderator Cynthia Ma, MD, PhD, a @washumedicine medical oncologist, as @ASCO’s Rapid Oral Abstract on Developmental Therapeutics winds down at 11:15 a.m. CT today, room E451.
For more, follow us and visit siteman.wustl.edu/asco/
English